| About Us |
| News & Events |
| Research |
| Publications |
| Affiliates |
| Cores |
| Other Resources |
| Useful Links |
| Contact Information |
| News & Events Archives |
| Copyright © 2009 by the President and Fellows of Harvard College |
Aperis G, Fuchs BB, Anderson, CA, Warner JE, Calderwood SB, and Mylonakis E (2007). Galleria mellonella as a model host to study infection by the Francisella tularensis live vaccine strain. Microbes Infect 9, 729-734.
Breger J, Fuchs BB, Aperis G, Moy TI, Ausubel FM, and Mylonakis E (2007). Antifungal Chemical Compounds Identified Using a C. elegans Pathogenicity Assay. PLoS Pathog 3, e18.
Cai S, and Singh BR (2007). Strategies to design inhibitors of Clostridium botulinum neurotoxins. Infect Disord Drug Targets 7, 47-57.
Cheng B, Liu IF, and Tse-Dinh YC (2007). Compounds with antibacterial activity that enhance DNA cleavage by bacterial DNA topoisomerase I. J Antimicrob Chemother 59, 640-645.
Finberg RW, Wang JP, and Kurt-Jones EA (2007). Toll like receptors and viruses. Rev Med Virol 17, 35-43.
Finberg RW, and Kurt-Jones EA (2007). Tolls: you pay them on the way in and on the way out! J Infect Dis 196, 497-498.
Ghose C, Kalsy A, Sheikh A, Rollenhagen J, John M, Young J, Rollins SM, Qadri F, Calderwood SB, Kelly CP, and Ryan ET (2007). Transcutaneous immunization with Clostridium difficile toxoid A induces systemic and mucosal immune responses and toxin A-neutralizing antibodies in mice. Infect Immun 75, 2826-2832.
Guertin RP, Harrison N, Zhou ZX, McCall S, and Drymiotis F (2007). Very high field magnetization and ac susceptibility of native horse spleen ferritin. J of Magnetism and Magnetic materials 308.
Junker LM, and Clardy J (2007). High-throughput screens for small-molecule inhibitors of Pseudomonas aeruginosa biofilm development. Antimicrob Agents Chemother 51, 3582-3590.
Juris SJ, Melnyk RA, Bolcome RE 3rd, Chan, J., and Collier RJ (2007). Cross-linked forms of the isolated N-terminal domain of the lethal factor are potent inhibitors of anthrax toxin. Infect Immun 75, 5052-5058.
Kuhn JH, Li W, Radoshitzky SR, Choe H, and Farzan M (2007). Severe acute respiratory syndrome coronavirus entry as a target of antiviral therapies. Antivir Ther 12, 639-650.
Kukreja RV, and Singh BR (2007). Comparative role of neurotoxin-associated proteins in the structural stability and endopeptidase activity of botulinum neurotoxin complex types A and E. Biochemistry 46, 14316-14324.
Kukreja RV, Sharma S, Cai S, and Singh BR (2007). Role of two active site Glu residues in the molecular action of botulinum neurotoxin endopeptidase. Biochim Biophys Acta 1774, 213-222.
Li W, Sui J, Huang IC, Kuhn JH, Radoshitzky SR, Marasco WA, Choe H, and Farzan M (2007). The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2. Virology 367, 367-374.
Maresso AW, Wu R, Kern JW, Zhang R, Janik D, Missiakas DM, Duban ME, Joachimiak A, and Schneewind O (2007). Activation of inhibitors by sortase triggers irreversible modification of the active site. J Biol Chem 282, 23129-23139.
Murthy T, Rolfs A, Hu Y, Shi Z, Raphael J, Moreira D, Kelley F, McCarron S, Jepson D, Taycher E, Zuo, D., Mohr SE, Fernandez M, Brizuela L, and LaBaer J (2007). A full-genomic sequence-verified protein-coding gene collection for Francisella tularensis. PLoS ONE 2, e577.
Pan N, Lee, C., and Goguen, J. (2007). High throughput screening for small-molecule inhibitors of type III secretion in Yersinia pestis. Adv Exp Med Biol 603, 367-375.
Parikh S, and Singh BR (2007). Comparative membrane channel size and activity of botulinum neurotoxins A and E. Protein J 26, 19-28.
Petit CM, Chouljenko VN, Iyer A, Colgrove R, Farzan M, Knipe DM, and Kousoulas KG (2007). Palmitoylation of the cysteine-rich endodomain of the SARS-coronavirus spike glycoprotein is important for spike-mediated cell fusion. Virology 360, 264-274.
Pouliot K, Pan N, Wang S, Lu S, Lien E, and Goguen JD (2007). Evaluation of the role of LcrV-Toll-like receptor 2-mediated immunomodulation in the virulence of Yersinia pestis. Infect Immun 75, 3571-3580.
Radoshitzky SR, Abraham J, Spiropoulou CF, Kuhn JH, Nguyen D, Li W, Nagel, J., Schmidt, P. J., Nunberg, J. H., Andrews NC, Farzan M, and Choe H (2007). Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses. Nature 446, 92-96.
Saenz JB, Doggett TA, and Haslam DB (2007). Identification and characterization of small molecules that inhibit intracellular toxin transport. Infect Immun 75, 4552-4561.
Sebastian S, Dillon ST, Lynch JG, Blalock LT, Balon E, Lee KT, Comstock, L. E., Conlan, J. W., Rubin EJ, Tzianabos, A. O., and Kasper DL (2007). A defined O-antigen polysaccharide mutant of Francisella tularensis live vaccine strain has attenuated virulence while retaining its protective capacity. Infect Immun 75, 2591-2602.
Shakhnovich EA, Hung DT, Pierson E, Lee K, and Mekalanos JJ (2007). Virstatin inhibits dimerization of the transcriptional activator ToxT. Proc Natl Acad Sci U S A 104, 2372-2377.
Veiga E, Guttman JA, Bonazzi M, Boucrot E, Toledo-Arana A, Lin AE, Enninga J, Pizarro-Cerda J, Finlay BB, Kirchhausen T, and Cossart P (2007). Invasive and adherent bacterial pathogens co-Opt host clathrin for infection. Cell Host Microbe 2, 340-351.
Wang JP, Asher DR, Chan M, Kurt-Jones EA, and Finberg RW (2007). Cutting Edge: Antibody-mediated TLR7-dependent recognition of viral RNA. J Immunol 178, 3363-3367.
Wang JP, Kurt-Jones EA, and Finberg RW (2007). Innate immunity to respiratory viruses. Cell Microbiol 9, 1641-1646.
Xie J, and Seto CT (2007). A two stage click-based library of protein tyrosine phosphatase inhibitors. Bioorg Med Chem 15, 458-473.
Zhou Y, Paturi S, Lindo P, Shoesmith SM, and Singh BR (2007). Cloning, expression, purification, and characterization of biologically active recombinant hemagglutinin-33, type A botulinum neurotoxin associated protein. Protein J 26, 29-37.
Zhou S, Kurt-Jones EA, Fitzgerald KA, Wang JP, Cerny AM, Chan M, and Finberg RW (2007). Role of MyD88 in route-dependent susceptibility to vesicular stomatitis virus infection. J Immunol 178, 5173-5181.